drugset / Trial / NCT03250975

Incidence of Acute Laryngeal Injury Following Endotracheal Intubation

NCT03250975

Phase 1/2 Active not recruiting 64 enrolled Vanderbilt University Medical Center
RandomizedParallel-groupDouble-blindDiagnostic

Summary

The purpose of this investigation is to delineate the incidence of acute and chronic laryngeal injury following intubation within our health system. In addition, this study seeks to identify risk factors for airway injury that may provide information to help reduce the incidence of injury or increase the speed of diagnosis through hospital based process measures. Study Aims 1. Determine the incidence of acute laryngeal injury in patients with prolonged intubation. 2. Determine the incidence of chronic laryngeal injury in the subset of patients with acute laryngeal injury 3. Initiate a randomized control trial to investigate the ability of azithromycin and budesonide to improve objective and subjective breathing measures in patients with Acute Laryngeal injury (ALgI) following endotracheal intubation.

Timeline

Start
2017-08-19
Primary completion
2026-12-30
Completion
2026-12-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule 250 mg
Subject Budesonide Small molecule 0.5 mg Inhaled

Indications

No indication recorded.